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INTRODUCTION
Inflammatory bowel disease includes
ulcerative colitis and Crohn's disease.
Etiology is unknown and acute exacerba-
tions and remissions are frequent.
Pathogenesis is also unclear. Extra-intesti-
nal features have been described and sev-
eral skin manifestations have been associ-
ated with the disease. Some of them can
precede bowel involvement but others
used to acommpany acute exacerbations or
appear during remission periods ofintesti-
nal disease. Among these skin manifesta-
tions some acute dermatosis like neu-
trophilic dermatosis have been reported.
Sweet's syndrome, pyoderma gangreno-
sum, erythema elevatum diutinum, sub-
comeal pultular dermatosis, pyostomatitis
vegetans, and vesiculopustular eruption
have been proposed to represent manifes-
tations along a continuum of neutrophilic
dermatosis [1]. Nevertheless, ulcerative
colitis is rarely associated with Sweet's
syndrome. We report a case of acute onset
ofulcerative colitis and Sweet's syndrome
focusing into its pathophysiology and
reviewing the literature.
CASE REPORT
A 52-year-old man was admitted to
hospital because of fever, lower gastroin-
testinal bleeding and skin lesions. He was
otherwise healthy except forprevious mild
depression. The patient was not taking any
medication. He reported bloody feces for
association with diffuse abdominal pain
for the last three weeks. Fever began two
days before admission with the onset of
red and tender skin lesions. On physical
exploration his body temperature was
38.5°C. The patient presented disseminat-
ed erythematous, tender plaques and nod-
ules on the trunk, especially back, and
both arns. Laboratory tests disclosed ery-
throcyte sedimentation rate 79 (Normal
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range 0 to 20 mm/hr), C-reactive protein
10.5 (Normal range 0 to 5 mg/dl), white
cell count 13.3 (Normal range 4.0 to 10.0
x 103/mm3 (80 percent neutrophils),
platelet count 651,000 (Normal range
100,000 to 350,000/mm3). Other bio-
chemical tests were normal as were blood
coagulation and urinanalysis. Antinuclear
antibodies (ANA)b were negative.
Antineutrophil cytoplasmic antibodies
(ANCA) were positive (1/160-pANCA).
Blood culture specimens were negative.
An EKG, chest radiographic film and an
abdominal ultrasonographic study showed
no abnormalities. Colonoscopy explo-
ration disclosed intense proctitis affecting
the last 15 cm with multiple ulcerative
lesions. Colonic biopsy was conclusive
with ulcerative colitis. A skin biopsy
showed a dense infiltration of neutrophils
establishing the diagnosis of Sweet's syn-
drome. Intravenous treatment with
methylprednisolone at a dose of 60
mg/day was begun with rapid improve-
ment in skin and colonic lesions and com-
plete clinical recovery.
DISCUSSION
Sweet's syndrome, also known as
acute febrile neutrophilic dermatosis, is
characterized by the sudden onset offever,
leukocytosis, and tender, red inflammato-
ry, well-demarcated papules, plaques or
nodules usually affecting the face, neck,
upper limbs or back. These lesions show
dense neutrophilic infiltrates on histologic
examination [2]. Treatment of Sweet's
syndrome is based on systemic corticos-
teroids, usually successful, although
colchicine, dapsone, cyclosporin, potassi-
um iodide, indomethacin, doxycycline,
clofazamine, pentoxifylline, and other
immunosupressants have been used.
Spontaneous remissions have been report-
ed [2, 3].
Sweet's syndrome has been described
as occurring simultaneously in malignan-
cies, especially hematological dyscrasias
and in the absence of them [4]. In this
sense, the association with hematological
disorders has recently been favored by
demonstrating a rearrangement of the bcr
gene in DNA obtained from a skin lesion
as well as in blood DNA, indicating the
presence of leukemic cells within the skin
lesion [5].
Sweet's syndrome has also been
reported as an unusual extra-intestinal
manifestation of either Crohn's disease or
ulcerative colitis. In patients with inflam-
matory bowel disease, Sweet's syndrome
is more common in women, colonic
involvement, and patients with other
extra-intestinal features. The rash is asso-
ciated with active disease in up to 80 per-
cent but it may precede the onset of
intestinal disease. It has been also
described after proctocolectomy [1, 6]. In
a retrospective study of 16 patients with
Sweet's syndrome, only two patients (12
percent) suffered from malignancy and
one patient had been diagnosed from
ulcerative colitis previously [7]. In other
larger retrospective study of 29 patients
only fourhad an underlying disease (poly-
cythemia, sarcoidosis, lymphoma, and
ulcerative colitis) [3]. Some immune sys-
tem disorders such as subacute thyroiditis,
rheumatoid arthritis, ankylosing spondyli-
tis, dermatomyositis, Behcet's disease,
SjoSgren's syndrome, sarcoidosis and other
immunologic diseases have been reported
in association with Sweet's syndrome [8-
10]. Recently, Sweet's syndrome has been
described during granulocyte colony-stim-
ulating factor (G-CSF) therapy. In some of
these patients, clinical presentation of the
syndrome was not typical because of the
appearance of gingival lesions [11, 12]. It
has also been associated with primary T-
cell immunodeficiency disease but these
patients may fail to respond to standard
treatment of Sweet's syndrome and suffer
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In other study, Mallolas et al. assessed
sera from 18 ulcerative colitis patients
known to be positive for perinuclear IgG-
ANCA (antineutrophil cytoplasmic anti-
bodies) by indirect immunofluorescence
in order to identify ANCA in non-apoptot-
ic and apoptotic neutrophils. They found
that the most frequent localization of
ANCA on scanning laser immunofluores-
cence microscopy in non-apoptotic neu-
trophils was in the nuclear periphery (50
percent). In all sera, ANCA fluorescence
co-localized almost completely with apop-
totic DNA. These data suggest an intracel-
lular DNA redistribution during neutrophil
apoptosis and a possible role of neu-
trophils in antigen exposure to the immune
system [14]. Another study, using fluid
samples of whole gut lavage with a poly-
ethylene glycol electrolyte solution,
showed that neutrophils migrate into the
gut wall and lumen and patients with
inflammation have significantly higher
levels of cytokines IL-1 I3 and IL-8 in the
whole gut lavage fluid [15].
We propose an underlying common
alteration in the immune system (especial-
ly neutrophilic response) in patients with
ulcerative colitis and in patients with
Sweet's syndrome. In this sense, there is
neutrophilic infiltration of the colonic
mucosa in ulcerative colitis and about a
third ofpatients with that disease have cir-
culating ANCA. Neutrophils appear to be
fundamentally important in Sweet's syn-
drome and ANCA has been identified in
this neutrophilic disorder [1, 4]. As we
have seen, in vitro studies suggest that
ANCA may play a pathogenic role in the
activation of neutrophils, and it has been
theorized that endogenous G-CSF may
play a role in Sweet's syndrome by stimu-
lating the production, activation, matura-
tion and chemotaxis in neutrophils [12].
Factors influencing neutrophilic influx
into apparently normal skin are not well
defined but might be explained on the
basis of cytokine activity and ANCA acti-
vation affecting granulopoiesis.
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